Tesla
TSLA
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.340
- -0.010-0.74%
Close Dec 17 16:00 ET
- 1.340
- 0.0000.00%
Post 20:02 ET
40.04MMarket Cap-0.67P/E (TTM)
1.370High1.320Low151.96KVolume1.340Open1.350Pre Close203.30KTurnover1.05%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.46P/B19.39MFloat Cap0.87052wk Low--Dividend TTM14.47MShs Float23.580Historical High--Div YieldTTM3.70%Amplitude0.870Historical Low1.337Avg Price1Lot Size
About AN2 Therapeutics Company
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Company Profile
SymbolANTX
Company NameAN2 Therapeutics
Listing DateMar 25, 2022
Issue Price15.00
Founded2017
CEOMr. Eric Easom
MarketNASDAQ
Employees41
Fiscal Year Ends12-31
Address1800 El Camino Real,Suite D
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94027
Phone1-650-331-9090
Company Executives
- Name
- Position
- Salary
- Eric Easom
- Chief Executive Officer, President and Director
- 3.34M
- Dr. Sanjay Chanda, PhD
- Chief Development Officer
- --
- Joshua M. Eizen, J.D.
- Chief Legal Officer and Chief Operating Officer
- --
- Lucy O. Day
- Chief Financial Officer and Principal Accounting Officer
- 1.52M
- Kevin Krause
- Chief Strategy Officer
- --
- Joseph S. Zakrzewski
- Chairman of the Board
- 179.64K
- Stephanie Wong
- Independent Director
- 157.14K
- Patricia Martin
- Independent Director
- 153.14K
- Kabeer Aziz
- Independent Director
- 145.64K
- Dr. Rob Readnour, PhD
- Independent Director
- 146.14K
- Gilbert Lynn Marks
- Independent Director
- 145.64K
- Dr. Melvin K. Spigelman,M.D.
- Independent Director
- 145.64K
- Margaret M. FitzPatrick, M.A.
- Independent Director
- 142.14K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.